About Us
About Us
Using Cancer Against Itself
Our therapeutic hijacks the cancer cell and recruits cancer-causing transcription factors to drive a multimodal immunotherapy.
Team Members
Ariel Yusupov, Founder/CEO
MS in Biophysics, Georgetown University
MD candidate, NYMC
Dr. Mark N. Stein, MD
Columbia University Medical Center
Dr. Matthew Dallos, MD
Memorial Sloane Kettering Cancer Center
Dr. Jenny Zilberberg, PhD
Head of Research, Imvax, Inc.
